These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1201227)

  • 1. A five year experience of the use of factor IX type DE(I) concentrate for the treatment of Christmas disease of Oxford.
    Lane JL; Rizza CR; Snape TJ
    Br J Haematol; 1975 Aug; 30(4):435-46. PubMed ID: 1201227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial changes in the coagulation system following clotting factor concentrate infusion.
    Preston FE; Winfield DA; Malia RG; Blackburn EK
    Thromb Diath Haemorrh; 1975 Nov; 34(2):475-82. PubMed ID: 1198408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated intravascular coagulation after factor IX complex resolved using purified factor IX concentrate.
    Hadley T; Djulbegovic B
    Ann Intern Med; 1991 Oct; 115(8):621-2. PubMed ID: 1892334
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of Christmas disease and Stuart-Prower deficiency with a prothrombin-complex concentrate (factors II, VII, IX, X).
    Tullis JL; Melin M
    Bibl Haematol; 1968; 29():1134-9. PubMed ID: 5700309
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation and properties of a therapeutic factor IX concentrate.
    Suomela H; Myllylä G; Raaska E
    Vox Sang; 1977 Jul; 33(1):37-50. PubMed ID: 883244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Substitution treatment in hemophilia. Critical measures and complications].
    Schimpf K
    Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
    [No Abstract]   [Full Text] [Related]  

  • 7. Disseminated intravascular coagulation and hemorrhage in hemophilia B following elective surgery.
    Conlan MG; Hoots WK
    Am J Hematol; 1990 Nov; 35(3):203-7. PubMed ID: 2220765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated F IX concentrate (FEIBA) used in the treatment of haemophilic patients with antibody to F VIII.
    Stenbjerg S; Jørgensen J
    Acta Med Scand; 1978; 203(6):471-6. PubMed ID: 665313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor IX concentrate compared with a prothrombin complex concentrate.
    Ruiz-Sáez A; Hong A; Arguello A; Echenagucia M; Boadas A; Fabbrizzi F; Minichilli F; Bosch NB
    Haemophilia; 2005 Nov; 11(6):583-8. PubMed ID: 16236107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a pure factor IX concentrate in a patient with moderate hemophilia B undergoing bilateral total hip replacement.
    Tengborn L; Stigendal L; Gustafsson G; Strömberg C; Hultmark P
    Transfusion; 1993; 33(11):936-9. PubMed ID: 8259599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to activated F IX concentrate (FEIBA).
    Stenbjerg S; Jorgensen J
    Scand J Haematol; 1977 May; 18(5):421-6. PubMed ID: 877518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor IX concentrate versus prothrombin complex concentrate for the treatment of hemophilia B during surgery.
    Bardin JM; Sultan Y
    Transfusion; 1990 Jun; 30(5):441-3. PubMed ID: 2360238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.
    Small M; Lowe GD; Douglas JT; Forbes CD; Prentice CR
    Thromb Haemost; 1982 Aug; 48(1):76-7. PubMed ID: 7135346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy.
    Gazzard BG; Henderson JM; Williams R
    Gut; 1975 Aug; 16(8):621-5. PubMed ID: 1102399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical use of factor IX concentrates].
    Nyman D
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1188-90. PubMed ID: 1215901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.
    Gazzard BG; Lewis ML; Ash G; Rizza CR; Bidwell E; Williams R
    Gut; 1974 Dec; 15(12):993-8. PubMed ID: 4448416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor IX complex.
    Aronson DL
    Semin Thromb Hemost; 1979; 6(1):28-43. PubMed ID: 390713
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastrectomy in siblings with Christmas disease (hemophilia B).
    Mizumoto R; Kawarada Y; Ogura Y
    Jpn J Surg; 1980 Dec; 10(4):328-37. PubMed ID: 6971362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.